Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma
Neuro-Oncology · 04.11.2024 · 26 (11) · 2027-2043
DOI: 10.1093/neuonc/noae134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 18.07.2024. Verfasst von Madhura Ketkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai 400094, India. Hauptthemen laut MEDLINE: Glioblastoma, Cellular Senescence, Unfolded Protein Response, eIF-2 Kinase. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Science and Technology (DST), The Department of Biotechnology, Department of Atomic Energy (DAE).
Abstract (Originalsprache)
Background
Glioblastoma due to recurrence is clinically challenging with 10–15 months overall survival. Previously we showed that therapy-induced senescence (TIS) in glioblastoma reverses causing recurrence. Here, we aim to delineate the TIS reversal mechanism for potential therapeutic intervention to prevent glioblastoma (GBM) recurrence.
Methods
Residual senescent (RS) and end of residual senescence (ERS) cells were captured from GBM patient-derived primary-cultures and cell lines mimicking clinical scenarios. RNA-sequencing, transcript/protein validations, knock-down/inhibitor studies, ChIP RT-PCR, biochemical assays, and IHCs were performed for the mechanistics of TIS reversal. In vivo validations were conducted in GBM orthotopic mouse model.
Results
Transcriptome analysis showed co-expression of endoplasmic reticulum (ER) stress-unfolded protein response (UPR) and senescence-associated secretory phenotype (SASP) with TIS induction and reversal. Robust SASP production and secretion by RS cells could induce senescence, Reactive oxygen specis (ROS), DNA damage, and ER stress in paracrine fashion independent of radiation. Neutralization of most significantly enriched cytokine from RS-secretome IL1β, suppressed SASP, and delayed senescence reversal. Mechanistically, with SASP and massive protein accumulation in ER, RS cells displayed stressed ER morphology, upregulated ER stress markers, and PERK pathway activation via peIF2α-ATF4-CHOP which was spontaneously resolved in ERS. ChIP RT-PCR showed CHOP occupancy at CXCL8/IL8, CDKN1A/p21, and BCL2L1/BCLXL aiding survival. PERK knockdown/inhibition with GSK2606414 in combination with radiation led to sustained ER stress and senescence without SASP. PERKi in RS functioned as senolytic via apoptosis and prevented recurrence in vitro and in vivo ameliorating overall survival.
Conclusion
We demonstrate that PERK-mediated UPR regulates senescence reversal and its inhibition can be exploited as a potential seno-therapeutic option in glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai 400094, India.
- Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai 410210, India.
- Integrated Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Navi Mumbai, 410210India.
- Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai 410210, India.
- Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai 410210, India.
- Integrated Cancer Genomics Laboratory, Department of Genetics, University of Delhi South Campus, Benito Juarez Marg, New Delhi 110021, India.
ORCID-Profile: Madhura Ketkar, Shilpee Dutt
Förderung
- Department of Science and Technology (DST)
- The Department of Biotechnology
- Department of Atomic Energy (DAE)
Zitieren
APA
Ketkar, M., Desai, S., Rana, P., Thorat, R., Epari, S., Dutt, A., & Dutt, S. (2024). Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro-Oncology, 26(11), 2027-2043. https://doi.org/10.1093/neuonc/noae134
Vancouver
Ketkar M, Desai S, Rana P, Thorat R, Epari S, Dutt A, et al. Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro-Oncology. 2024;26(11):2027-2043. doi:10.1093/neuonc/noae134
BibTeX
@article{Ketkar2024,
author = {Ketkar, Madhura and Desai, Sanket and Rana, Pranav and Thorat, Rahul and Epari, Sridhar and Dutt, Amit and Dutt, Shilpee},
title = {Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma},
journal = {Neuro-Oncology},
year = {2024},
volume = {26},
number = {11},
pages = {2027--2043},
doi = {10.1093/neuonc/noae134}
}
EUVIMED